You are here

Aline Renneville

Aline Renneville, Ph.D.

Aline Renneville is a research scientist I in the Cancer Program of the Broad Institute of MIT and Harvard, where she works under the direction of Benjamin L. Ebert to identify and validate proteins that can be targeted by new molecules from the immunomodulatory drugs family (derivatives of thalidomide) and identify diseases that potentially are susceptible to these new molecules.

Prior to joining the Broad Institute in May 2017, Renneville completed a postdoctoral fellowship at Brigham and Women’s Hospital in Boston. She had previously worked at the Laboratory of Hematology at the Biology and Pathology Center, Lille University Hospital, France.

Renneville obtained her Pharm.D. and Ph.D. from the University of Lille, France.

Contact Aline Renneville via email at arennevi@broadinstitute.org.

March 2018